Apos Medical Assets Ltd. is a global medical device company, owned by leading healthcare fund aMoon and operating in four countries: the United Kingdom, the United States, and Israel.
Founded in 2005, the company distributes the CE marked and FDA cleared AposTherapy® treatment to both large hospitals and private physiotherapy clinics. To date, over 98,000 patients suffering from knee, hip, ankle and lower back pain have been treated worldwide.
The company adheres to high clinical and scientific standards. Currently, over 50 research papers have been published, providing proof of concept of the treatment’s mechanism of action as well as giving scientific backing to the positive clinical effects AposTherapy® has in a variety of lower limb and low back conditions.
Musculoskeletal pathologies of the knee, hip, ankle and lower back are characterised by an increased load on the problematic areas and poor muscle control, causing pain and difficulty in performing daily activities such as walking and using the stairs.
AposTherapy® is an innovative treatment, that uses a personalised footworn device administered by specially trained physiotherapists.
The treatment improves biomechanical and neuromuscular function by simultaneously reducing the load on the affected area of the joint and optimising muscular control to retain the improved movement patterns – providing long-term “carry over” results that keep even while not wearing the device.
By improving body mechanics and muscular coordination, AposTherapy® has been shown, in clinical studies, to relieve pain and improve daily function and quality of life.
AposTherapy® provides an effective alternative to surgery for patients who want, or need, a non-invasive approach.
CE marking &
Get back to what you love to do
Sign up for a free consultation with our trained professionals.